Results for TAR-200 + Cetrelimab in Muscle-Invasive Bladder … : Oncology Times
An abstract is unavailable.
Related Articles
NF1-Associated PN Community Insights: Key Questions, Expert Answers
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer
Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.
IASLC’s Regional Course Series | IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and…
Correlation of different HPV genotype viral loads and cervical lesions: A retrospective analysis of 1585 cases
Viral loads of human papillomavirus (HPV)16, HPV31, HPV33, HPV35, and HPV58 were significantly associated with the grade of cervical lesions. The viral load of specific…
Tolebrutinib Is First Drug to Delay Disability Onset in… : Neurology Today
An abstract is unavailable.
LBL-024 Gains FDA Orphan Drug Status in Neuroendocrine Cancer
LBL-024, a bispecific antibody targeting PD-L1 and 4-1BB, has received FDA orphan drug designation for neuroendocrine cancer treatment.
Follow-Up After Resection of Pancreatic Adenocarcinoma
This cross-sectional study investigates if there are differences in the receipt of recurrence-focused treatment and overall survival in patients with pancreatic ductal adenocarcinoma recurrence who…
Obe-Cel Stands Out in ALL as the Sole FDA-Approved CAR T-Cell Therapy Given Via Split Dosing
Elias Jabbour, MD, highlights the significance of obecabtagene autoleucel’s approval for patients with B-cell precursor ALL and data from the FELIX trial.
Catatonia Optimized With ECT and Maintenance IV Lorazepam… : The Journal of ECT
An abstract is unavailable.
Saad Z. Usmani: Engaging discussions at this year’s Myeloma Meeting – OncoDaily
Saad Z. Usmani: Engaging discussions at this year’s Myeloma Meeting / cancer, Marivi Mateos, Memorial Sloan Kettering Cancer Center, Mohamad Mohty, Noopur
